Press Releases

Stay up-to-date with the latest announcements from the SGC.

Explore our official press releases to stay updated on our major accomplishments and new partnerships. Want to be the first to know about the latest news from SGC?

 

Takeda and SGC Announce a Collaboration Agreement Using Patient Tissue-Based Assays for Clinical Target Validation in Irritable Bowel Disease

Osaka, Japan, San Diego, Calif., USA, and Stockholm, Sweden, September 28, 2017— Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502), Karolinska Institutet (“KI”) and The Structural Genomics Consortium (“SGC”) today announced a combined pre-competitive and proprietary…

New support for Structural Genomics Consortium and open science

Left to right: Dr. Martin Osmond, CEO and Scientific Director of the CHEO Research Institute; Marc LePage, President and CEO, Genome Canada; Jennifer Chan, VP, Policy and External Affairs, Merck Canada; Hon. Reza Moridi, Ontario Minister of Research, Innovation and Science; Dr. Cheryl…

The Alzheimer’s Research UK Drug Discovery Alliance and the SGC announce their collaboration in dementia research

We announce today a groundbreaking partnership between the Alzheimer’s Research UK Drug Discovery Alliance (DDA) and the Structural Genomics Consortium (SGC), an international group of academic and industrial researchers with a strong track record in uncovering new drug targets and enabling new…